A comprehensive view of men's health issues. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA approves Astellas and Pfizer's XTANDI, the first androgen receptor signaling inhibitor for nonmetastatic castration-sensitive prostate cancer
Published: November 17, 2023 by PR Newswire
Pfizer’s oral Talzenna in combination with Xtandi receives CHMP positive opinion in the European Union for adult patients with metastatic castration-resistant prostate cancer; about 470,000 new cases of prostate cancer were reported in Europe in 2020
Published: November 15, 2023 by Contify Life Science News
Astrazeneca launches initiative to donate advanced ultrasound biopsy machines to Kenyan hospitals in partnership with NCI Kenya and KAUS, aiming to enhance early prostate cancer diagnosis and improve patient outcomes
Published: November 06, 2023 by Science Africa
FDA declares Pluvicto drug shortage resolved due to Novartis' significant production scale-up efforts; the company has more than doubled its weekly production capacity since May, with additional production expansion planned into 2024
Published: October 27, 2023 by ENP Newswire
Eli Lilly listed a new US clinical trial to study abemaciclib plus darolutamide to treat men with metastatic castration-resistant prostate cancer; study to learn about safety of combo therapy to treat cancer that has spread after initial treatment
Published: August 28, 2023 by Contify Life Science News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count